EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | H2O.C29H31ClFN5O5 |
| Net Charge | 0 |
| Average Mass | 602.063 |
| Monoisotopic Mass | 601.21034 |
| SMILES | COc1cc(F)cc([C@@H](CO)NC(=O)[C@@H](C)N2Cc3ccc(-c4nc(NC5CCOCC5)ncc4Cl)cc3C2=O)c1.O |
| InChI | InChI=1S/C29H31ClFN5O5.H2O/c1-16(27(38)34-25(15-37)19-9-20(31)12-22(10-19)40-2)36-14-18-4-3-17(11-23(18)28(36)39)26-24(30)13-32-29(35-26)33-21-5-7-41-8-6-21;/h3-4,9-13,16,21,25,37H,5-8,14-15H2,1-2H3,(H,34,38)(H,32,33,35);1H2/t16-,25-;/m1./s1 |
| InChIKey | ZZOBEXXCVGOKMK-JSYWXJBKSA-N |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| beroterkib (CHEBI:759911) has role antineoplastic agent (CHEBI:35610) |
| beroterkib (CHEBI:759911) is a alanine derivative (CHEBI:22278) |
| INN | Source |
|---|---|
| beroterkib | WHO MedNet |
| Synonyms | Source |
|---|---|
| Astx 029 | ChEMBL |
| ASTX-029 | ChEMBL |
| ASTX029 | ChEMBL |
| ASTX-029 MONOHYDRATE | ChEMBL |
| ASTX029 MONOHYDRATE | ChEMBL |
| AT35029 | ChEMBL |